Prof. Dr. Ludwig Plasswilm
chief physician
Department of Radiation Oncology · Dept. IV
Catalytic activity imperative for nanoparticle dose enhancement in photon and proton therapy.
Gerken L, Weber D, Plasswilm L, Meer D, Psoroulas S, Schiefer J, Gerdes M, David H, Starsich F, Gogos A, Herrmann I. Catalytic activity imperative for nanoparticle dose enhancement in photon and proton therapy. Nat Commun 2022; 13:3248.
Jun 6, 2022Catalytic activity imperative for nanoparticle dose enhancement in photon and proton therapy.
Jun 6, 2022Nat Commun 2022; 13:3248
Gerken Lukas R H, Weber Damien C, Plasswilm Ludwig, Meer David, Psoroulas Serena, Schiefer Johann, Gerdes Maren E, David Helena, Starsich Fabian H L, Gogos Alexander, Herrmann Inge K
Validation of the Decipher genomic classifier in patients receiving salvage radiotherapy without hormone therapy after radical prostatectomy - an ancillary study of the SAKK 09/10 randomized clinical trial.
Dal Pra A, Ghadjar P, Hayoz S, Liu V, Spratt D, Thompson D, Davicioni E, Huang H, Zhao X, Liu Y, Scharf C, Gut P, Plasswilm L, Hölscher T, Polat B, Hildebrandt G, Müller A, Pollack A, Thalmann G, Zwahlen D, Aebersold D. Validation of the Decipher genomic classifier in patients receiving salvage radiotherapy without hormone therapy after radical prostatectomy - an ancillary study of the SAKK 09/10 randomized clinical trial. Ann Oncol 2022; 33:950-958.
May 28, 2022Validation of the Decipher genomic classifier in patients receiving salvage radiotherapy without hormone therapy after radical prostatectomy - an ancillary study of the SAKK 09/10 randomized clinical trial.
May 28, 2022Ann Oncol 2022; 33:950-958
Dal Pra Alan, Ghadjar Pirus, Hayoz S, Liu V Y T, Spratt D E, Thompson D J S, Davicioni E, Huang H-C, Zhao X, Liu Yali, Scharf Christop, Gut P, Plasswilm Ludwig, Hölscher Tobias, Polat Bülent, Hildebrandt G, Müller A-C, Pollack A, Thalmann G N, Zwahlen D, Aebersold D M
Role of Adjuvant Radiotherapy in Non-Small Cell Lung Cancer-A Review.
Süveg K, Plasswilm L, Iseli T, Leskow P, Fischer G, Putora P. Role of Adjuvant Radiotherapy in Non-Small Cell Lung Cancer-A Review. Cancers (Basel) 2022; 14
Mar 23, 2022Role of Adjuvant Radiotherapy in Non-Small Cell Lung Cancer-A Review.
Mar 23, 2022Cancers (Basel) 2022; 14
Süveg Krisztian, Plasswilm Ludwig, Iseli Thomas, Leskow Pawel, Fischer Galina Farina, Putora Paul Martin
Role of Brachytherapy in the Postoperative Management of Endometrial Cancer: Decision-Making Analysis among Experienced European Radiation Oncologists.
Glatzer M, Petric P, van der Steen-Banasik E, Lössl K, Jürgenliemk-Schulz I, Niehoff P, Hermansson R, Nout R, Putora P, Plasswilm L, Nakken E, Cooper R, Tanderup K, Rovirosa A, Fokdal L, Ordeanu C, Tagliaferri L, Chargari C, Strnad V, Dimopoulos J, Šegedin B, Tselis N. Role of Brachytherapy in the Postoperative Management of Endometrial Cancer: Decision-Making Analysis among Experienced European Radiation Oncologists. Cancers (Basel) 2022; 14
Feb 11, 2022Role of Brachytherapy in the Postoperative Management of Endometrial Cancer: Decision-Making Analysis among Experienced European Radiation Oncologists.
Feb 11, 2022Cancers (Basel) 2022; 14
Glatzer Markus, Petric Primoz, van der Steen-Banasik Elzbieta, Lössl Kristina, Jürgenliemk-Schulz Ina M, Niehoff Peter, Hermansson Ruth S, Nout Remi A, Putora Paul Martin, Plasswilm Ludwig, Nakken Esten Søndrol, Cooper Rachel, Tanderup Kari, Rovirosa Angeles, Fokdal Lars, Ordeanu Claudia, Tagliaferri Luca, Chargari Cyrus, Strnad Vratislav, Dimopoulos Johannes Athanasios, Šegedin Barbara, Tselis Nikolaos
Radiotherapy or Surgery? Comparative, Qualitative Assessment of Online Patient Education Materials on Prostate Cancer
Vu E, Pratsinis M, Plasswilm L, Schmid H, Panje C, Betschart P. Radiotherapy or Surgery? Comparative, Qualitative Assessment of Online Patient Education Materials on Prostate Cancer. Curr Oncol 2021; 28:3420-3429.
Sep 6, 2021Radiotherapy or Surgery? Comparative, Qualitative Assessment of Online Patient Education Materials on Prostate Cancer
Sep 6, 2021Curr Oncol 2021; 28:3420-3429
Vu Erwin, Pratsinis Manolis, Plasswilm Ludwig, Schmid Hans-Peter, Panje Cédric, Betschart Patrick
Dose-intensified Versus Conventional-dose Salvage Radiotherapy for Biochemically Recurrent Prostate Cancer After Prostatectomy: The SAKK 09/10 Randomized Phase 3 Trial
Ghadjar P, Zaugg K, Guckenberger M, Ost P, Reuter C, Bosetti D, Kaouthar K, Gomez S, Wust P, Thalmann G, Aebersold D, Sumila M, Schär C, Hayoz S, Bernhard J, Zwahlen D, Hölscher T, Gut P, Polat B, Hildebrandt G, Müller A, Plasswilm L, Papachristofilou A, Swiss Group for Clinical Cancer Research (SAKK). Dose-intensified Versus Conventional-dose Salvage Radiotherapy for Biochemically Recurrent Prostate Cancer After Prostatectomy: The SAKK 09/10 Randomized Phase 3 Trial. Eur Urol 2021; 80:306-315.
Jun 14, 2021Dose-intensified Versus Conventional-dose Salvage Radiotherapy for Biochemically Recurrent Prostate Cancer After Prostatectomy: The SAKK 09/10 Randomized Phase 3 Trial
Jun 14, 2021Eur Urol 2021; 80:306-315
Ghadjar Pirus, Zaugg Kathrin, Guckenberger Matthias, Ost Piet, Reuter Christiane, Bosetti Davide G, Kaouthar Khanfir, Gomez Silvia, Wust Peter, Thalmann George N, Aebersold Daniel M, Sumila Marcin, Schär Corinne, Hayoz Stefanie, Bernhard Jürg, Zwahlen Daniel R, Hölscher Tobias, Gut Philipp, Polat Bülent, Hildebrandt Guido, Müller Arndt-Christian, Plasswilm Ludwig, Papachristofilou Alexandros, Swiss Group for Clinical Cancer Research (SAKK)
Radiotherapy or surgery ? Comparative, qualitative assessment of online patient education materials on prostate cancer
Vue E, Pratsinis M, Plasswilm L, Schmid H, Panje C, Betschart P. Radiotherapy or surgery ? Comparative, qualitative assessment of online patient education materials on prostate cancer. Curr Oncol 2021; 28:3420-9.
Jan 1, 2021Radiotherapy or surgery ? Comparative, qualitative assessment of online patient education materials on prostate cancer
Jan 1, 2021Curr Oncol 2021; 28:3420-9
Vue E, Pratsinis Manolis, Plasswilm Ludwig, Schmid Hans-Peter, Panje CM, Betschart Patrick
Radiotherapy for lentigo maligna and lentigo maligna melanoma - a systematic review.
Hendrickx A, Cozzio A, Plasswilm L, Panje C. Radiotherapy for lentigo maligna and lentigo maligna melanoma - a systematic review. Radiat Oncol 2020; 15:174.
Jul 14, 2020Radiotherapy for lentigo maligna and lentigo maligna melanoma - a systematic review.
Jul 14, 2020Radiat Oncol 2020; 15:174
Hendrickx Alexandra, Cozzio Antonio, Plasswilm Ludwig, Panje Cédric M
Insular Decision Criteria in Clinical Practice: Analysis of Decision-Making in Oncology
Iseli T, Plasswilm L, Sirén C, Schmidt B, Rothermundt C, Hundsberger T, Glatzer M, Panje C, Fischer G, Putora P. Insular Decision Criteria in Clinical Practice: Analysis of Decision-Making in Oncology. Oncology 2020; 98:438-444.
May 19, 2020Insular Decision Criteria in Clinical Practice: Analysis of Decision-Making in Oncology
May 19, 2020Oncology 2020; 98:438-444
Iseli Thomas, Plasswilm Ludwig, Sirén Charlotta, Schmidt Barbara, Rothermundt Christian, Hundsberger Thomas, Glatzer Markus, Panje Cédric, Fischer Galina, Putora Paul Martin
Long-term oncological and functional follow-up in low-dose-rate brachytherapy for prostate cancer: results from the prospective nationwide Swiss registry
Viktorin-Baier P, Zürn K, Güsewell S, Schiefer J, Blick N, Müntener M, Stucki P, Suter S, Prikler L, Hochreiter W, Thoeni A, Schwab C, Plasswilm L, Schmid H, Putora P, Engeler D. Long-term oncological and functional follow-up in low-dose-rate brachytherapy for prostate cancer: results from the prospective nationwide Swiss registry. BJU Int 2020; 125:827-835.
Feb 12, 2020Long-term oncological and functional follow-up in low-dose-rate brachytherapy for prostate cancer: results from the prospective nationwide Swiss registry
Feb 12, 2020BJU Int 2020; 125:827-835
Viktorin-Baier Pascal, Zürn Karin, Güsewell Sabine, Schiefer Johann, Blick Nadja, Müntener Michael, Stucki Patrick, Suter Stefan, Prikler Ladislav, Hochreiter Werner, Thoeni Armin, Schwab Christoph, Plasswilm Ludwig, Schmid Hans-Peter, Putora Paul Martin, Engeler Daniel
A cost-effectiveness analysis of consolidation immunotherapy with durvalumab in stage III NSCLC responding to definitive radiochemotherapy in Switzerland
Panje C, Schwenkglenks M, Gautschi O, Plasswilm L, Aebersold D, Dedes K, Lorez M, Pardo E, Barbier M, Lupatsch J, Swiss Group for Clinical Cancer Research (SAKK). A cost-effectiveness analysis of consolidation immunotherapy with durvalumab in stage III NSCLC responding to definitive radiochemotherapy in Switzerland. Ann Oncol 2020; 31:501-506.
Jan 16, 2020A cost-effectiveness analysis of consolidation immunotherapy with durvalumab in stage III NSCLC responding to definitive radiochemotherapy in Switzerland
Jan 16, 2020Ann Oncol 2020; 31:501-506
Panje Cédric, Schwenkglenks M, Gautschi O, Plasswilm Ludwig, Aebersold D M, Dedes K J, Lorez M, Pardo E, Barbier M, Lupatsch J E, Swiss Group for Clinical Cancer Research (SAKK)
Langzeitresultate des prospektiven Schweizer Registers LDR-Brachytherapie des lokalisierten Prostatakarzinoms
Schmid H, Viktorin P, Putora P, Schiefer J, Schwab C, Plasswilm L, Engeler D. Langzeitresultate des prospektiven Schweizer Registers LDR-Brachytherapie des lokalisierten Prostatakarzinoms. German Medical Science, www.egms.de 2020
Jan 1, 2020Langzeitresultate des prospektiven Schweizer Registers LDR-Brachytherapie des lokalisierten Prostatakarzinoms
Jan 1, 2020German Medical Science, www.egms.de 2020
Schmid Hans-Peter, Viktorin P, Putora Paul Martin, Schiefer Johann, Schwab Christoph, Plasswilm Ludwig, Engeler Daniel
Radiotherapie bei schmerzhaften Metastasen
Iseli T, Plasswilm L. Radiotherapie bei schmerzhaften Metastasen - Konzept und Vorgehen in der klinischen Praxis. Schweizerische Zeitschrift für Onkologie 2019; 5:17-20.
Dec 13, 2019Radiotherapie bei schmerzhaften Metastasen
Dec 13, 2019Schweizerische Zeitschrift für Onkologie 2019; 5:17-20
Iseli Thomas, Plasswilm Ludwig
Skeletal muscle mass correlates with increased toxicity during neoadjuvant radiochemotherapy in locally advanced esophageal cancer: A SAKK 75/08 substudy
Panje C, Plasswilm L, Ruhstaller T, Gerard M, Hawle H, Schacher S, Henke G, Meier U, Garcia Schüler H, Herrmann E, Baracos V, Hayoz S, Höng L, Swiss Group for Clinical Cancer Research (SAKK). Skeletal muscle mass correlates with increased toxicity during neoadjuvant radiochemotherapy in locally advanced esophageal cancer: A SAKK 75/08 substudy. Radiat Oncol 2019; 14:166.
Sep 11, 2019Skeletal muscle mass correlates with increased toxicity during neoadjuvant radiochemotherapy in locally advanced esophageal cancer: A SAKK 75/08 substudy
Sep 11, 2019Radiat Oncol 2019; 14:166
Panje Cédric, Plasswilm Ludwig, Ruhstaller Thomas, Gerard Marie-Aline, Hawle Hanne, Schacher Sabina, Henke Guido, Meier Urs R, Garcia Schüler Helena, Herrmann Evelyn, Baracos Vickie E, Hayoz Stefanie, Höng Laura, Swiss Group for Clinical Cancer Research (SAKK)
[Modern Treatment Concepts in Radiation Oncology]
Plasswilm L, Studer G, Aebersold D, Zwahlen D. [Modern Treatment Concepts in Radiation Oncology]. Ther Umsch 2019; 76:209-218.
Sep 1, 2019[Modern Treatment Concepts in Radiation Oncology]
Sep 1, 2019Ther Umsch 2019; 76:209-218
Plasswilm Ludwig, Studer Gabriela, Aebersold Daniel M, Zwahlen Daniel R
End-to-End testing method for SRS patient QA based on a new multidetector array and comparison with two other techniques
Buchauer K, Socoliuctoquant A, Plasswilm L, Schiefer J (2019). End-to-End testing method for SRS patient QA based on a new multidetector array and comparison with two other techniques.
Aug 31, 2019End-to-End testing method for SRS patient QA based on a new multidetector array and comparison with two other techniques
Aug 31, 2019SASRO 2019
Buchauer Konrad, Socoliuctoquant A, Plasswilm Ludwig, Schiefer Johann
Pattern of failure after adjuvant radiotherapy following extrapleural pneumonectomy of pleural mesothelioma in the SAKK 17/04 trial
Riesterer O, Krayenbuehl J, Weder W, Sabrina Stark L, Zimmermann F, Nackaerts K, Zwahlen D, Mahmut Ozsahin E, Plasswilm L, Aebersold D, Xyrafas A, Stahel R, Ciernik I, Swiss Group for Clinical Cancer Research (SAKK). Pattern of failure after adjuvant radiotherapy following extrapleural pneumonectomy of pleural mesothelioma in the SAKK 17/04 trial. Radiother Oncol 2019; 138:121-125.
Jun 25, 2019Pattern of failure after adjuvant radiotherapy following extrapleural pneumonectomy of pleural mesothelioma in the SAKK 17/04 trial
Jun 25, 2019Radiother Oncol 2019; 138:121-125
Riesterer Oliver, Krayenbuehl Jerome, Weder Walter, Sabrina Stark L, Zimmermann Frank, Nackaerts Kristiaan, Zwahlen Daniel R, Mahmut Ozsahin E, Plasswilm Ludwig, Aebersold Daniel M, Xyrafas Alexandros, Stahel Rolf A, Ciernik I Frank, Swiss Group for Clinical Cancer Research (SAKK)
A cost-effectiveness analysis of consolidative local therapy in oligometastatic non-squamous non-small cell lung cancer (NSCLC)
Panje C, Lupatsch J, Plasswilm L, Aebersold D, Siano M, Gautschi O, Schwenkglenks M, Matter-Walstra K, Dedes K, Swiss Group for Clinical Cancer Research (SAKK). A cost-effectiveness analysis of consolidative local therapy in oligometastatic non-squamous non-small cell lung cancer (NSCLC). Radiother Oncol 2018; 129:257-263.
Aug 10, 2018A cost-effectiveness analysis of consolidative local therapy in oligometastatic non-squamous non-small cell lung cancer (NSCLC)
Aug 10, 2018Radiother Oncol 2018; 129:257-263
Panje Cédric, Lupatsch Judith E, Plasswilm Ludwig, Aebersold Daniel M, Siano Marco, Gautschi Oliver, Schwenkglenks Matthias, Matter-Walstra Klazien, Dedes Konstantin J, Swiss Group for Clinical Cancer Research (SAKK)
Bevacizumab plus hypofractionated radiotherapy versus radiotherapy alone in elderly patients with glioblastoma: the randomized, open-label, phase II ARTE trial
Wirsching H, Riklin C, Felsberg J, Roth P, Jones D, Pfister S, Rushing E, Abrey L, Reifenberger G, Held L, von Deimling A, Ochsenbein A, von Moos R, Caparrotti F, Tabatabai G, Roelcke U, Hottinger A, Jörger F, Schmid A, Plasswilm L, Schrimpf D, Mancao C, Capper D, Conen K, Hundsberger T, Weller M. Bevacizumab plus hypofractionated radiotherapy versus radiotherapy alone in elderly patients with glioblastoma: the randomized, open-label, phase II ARTE trial. Ann Oncol 2018; 29:1423-1430.
Jun 1, 2018Bevacizumab plus hypofractionated radiotherapy versus radiotherapy alone in elderly patients with glioblastoma: the randomized, open-label, phase II ARTE trial
Jun 1, 2018Ann Oncol 2018; 29:1423-1430
Wirsching H-G, Riklin C, Felsberg J, Roth P, Jones D T W, Pfister S, Rushing E J, Abrey L, Reifenberger G, Held L, von Deimling A, Ochsenbein A, von Moos R, Caparrotti F, Tabatabai G, Roelcke U, Hottinger A F, Jörger F, Schmid A, Plasswilm Ludwig, Schrimpf D, Mancao C, Capper D, Conen K, Hundsberger Thomas, Weller M
Late seed migration after prostate brachytherapy with Iod-125 permanent implants
Maletzki P, Schwab C, Markart P, Engeler D, Schiefer J, Plasswilm L, Schmid H. Late seed migration after prostate brachytherapy with Iod-125 permanent implants. Prostate Int 2018
Jan 1, 2018Late seed migration after prostate brachytherapy with Iod-125 permanent implants
Jan 1, 2018Prostate Int 2018
Maletzki P, Schwab Christoph, Markart P, Engeler Daniel, Schiefer Johann, Plasswilm Ludwig, Schmid Hans-Peter